Book contents
- Placental–Fetal Growth Restriction
- Placental–Fetal Growth Restriction
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Glossary and Commonly Used Abbreviations
- Section 1 Basic Principles
- Section 2 Maternal Cardiovascular Characteristics and the Placenta
- Section 3 Screening for Placental–Fetal Growth Restriction
- Section 4 Prophylaxis and Treatment
- Section 5 Characteristics of Fetal Growth Restriction
- Section 6 Management of Fetal Growth Restriction
- Section 7 Postnatal Aspects of Fetal Growth Restriction
- Chapter 26 Fetal Growth Restriction and Neonatal Outcomes
- Chapter 27 Fetal Growth Restriction and Later Disease in the Mother and the Offspring
- Chapter 28 Fetal Growth Restriction: Recurrence Risks and Counseling
- Index
- References
Chapter 28 - Fetal Growth Restriction: Recurrence Risks and Counseling
from Section 7 - Postnatal Aspects of Fetal Growth Restriction
Published online by Cambridge University Press: 23 July 2018
Book contents
- Placental–Fetal Growth Restriction
- Placental–Fetal Growth Restriction
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Glossary and Commonly Used Abbreviations
- Section 1 Basic Principles
- Section 2 Maternal Cardiovascular Characteristics and the Placenta
- Section 3 Screening for Placental–Fetal Growth Restriction
- Section 4 Prophylaxis and Treatment
- Section 5 Characteristics of Fetal Growth Restriction
- Section 6 Management of Fetal Growth Restriction
- Section 7 Postnatal Aspects of Fetal Growth Restriction
- Chapter 26 Fetal Growth Restriction and Neonatal Outcomes
- Chapter 27 Fetal Growth Restriction and Later Disease in the Mother and the Offspring
- Chapter 28 Fetal Growth Restriction: Recurrence Risks and Counseling
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Placental-Fetal Growth Restriction , pp. 263 - 268Publisher: Cambridge University PressPrint publication year: 2018
References
Singer, LT, Davillier, M, Bruening, P, Hawkins, S, Yamashita, TS. Social support, psychological distress, and parenting strains in mothers of very low birthweight infants. Fam Relat 1996 Jul 1;45(3):343–50.Google Scholar
Singer, LT, Salvator, A, Guo, S, Collin, M, Lilien, L, Baley, J. Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant. JAMA 1999 Mar 3;281(9):799–805.Google Scholar
Kusters, CD, Van der Pal, SM, Van Steenbrugge, GJ, Den Ouden, LS, Kollee, LA. [The impact of a premature birth on the family; consequences are experienced even after 19 years]. Ned Tijdschr Geneeskd 2013;157(25):A5449.Google Scholar
Schaaf, JM, Mol, BW, bu-Hanna, A, Ravelli, AC. Trends in preterm birth: Singleton and multiple pregnancies in the Netherlands, 2000–2007. BJOG 2011 Sep;118(10):1196–204.Google Scholar
Van Rijn, BB, Hoeks, LB, Bots, ML, Franx, A, Bruinse, HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006 Sep;195(3):723–8.CrossRefGoogle ScholarPubMed
Saemundsson, Y, Svantesson, H, Gudmundsson, S. Abnormal uterine artery Doppler in pregnancies suspected of a SGA fetus is related to increased risk of recurrence during next pregnancy. Acta Obstet Gynecol Scand 2009;88(7):814–17.Google Scholar
Patterson, RM, Gibbs, CE, Wood, RC. Birth weight percentile and perinatal outcome: Recurrence of intrauterine growth retardation. Obstet Gynecol 1986 Oct;68(4):464–8.Google Scholar
Hinkle, SN, Albert, PS, Mendola, P, Sjaarda, LA, Boghossian, NS, Yeung, E, et al. Differences in risk factors for incident and recurrent small-for-gestational-age birthweight: A hospital-based cohort study. BJOG 2014 Aug;121(9):1080–8.Google Scholar
Bakewell, JM, Stockbauer, JW, Schramm, WF. Factors associated with repetition of low birthweight: Missouri longitudinal study. Paediatr Perinat Epidemiol 1997 Jan;11 Suppl 1:119–29.Google Scholar
Voskamp, BJ, Kazemier, BM, Ravelli, AC, Schaaf, J, Mol, BW, Pajkrt, E. Recurrence of small-for-gestational-age pregnancy: Analysis of first and subsequent singleton pregnancies in The Netherlands. Am J Obstet Gynecol 2013 May;208(5):374–6.CrossRefGoogle ScholarPubMed
Kuno, N, Itakura, A, Kurauchi, O, Mizutani, S, Kazeto, S, Tomoda, Y. Decrease in severity of intrauterine growth retardation in subsequent pregnancies. Int J Gynaecol Obstet 1995 Dec;51(3):219–24.CrossRefGoogle ScholarPubMed
Bakketeig, LS, Bjerkedal, T, Hoffman, HJ. Small-for-gestational age births in successive pregnancy outcomes: Results from a longitudinal study of births in Norway. Early Hum Dev 1986 Dec;14(3–4):187–200.Google Scholar
Evers, AC, Van Rijn, BB, Van Rossum, MM, Bruinse, HW. Subsequent pregnancy outcome after first pregnancy with normotensive early-onset intrauterine growth restriction at <34 weeks of gestation. Hypertens Pregnancy 2011;30(1):37–44.CrossRefGoogle ScholarPubMed
Visser, GH, Huisman, A, Saathof, PW, Sinnige, HA. Early fetal growth retardation: Obstetric background and recurrence rate. Obstet Gynecol 1986 Jan;67(1):40–3.Google ScholarPubMed
Kinzler, WL, Kaminsky, L. Fetal growth restriction and subsequent pregnancy risks. Semin Perinatol 2007 Jun;31(3):126–34.Google Scholar
Andres, RL, Kuyper, W, Resnik, R, Piacquadio, KM, Benirschke, K. The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am J Obstet Gynecol 1990 Sep;163(3):935–8.Google Scholar
Bane, AL, Gillan, JE. Massive perivillous fibrinoid causing recurrent placental failure. BJOG 2003 Mar;110(3):292–5.Google Scholar
Katzman, PJ, Genest, DR. Maternal floor infarction and massive perivillous fibrin deposition: Histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol 2002 Mar;5(2):159–64.Google Scholar
Romero, R, Whitten, A, Korzeniewski, SJ, Than, NG, Chaemsaithong, P, Miranda, J, et al. Maternal floor infarction/massive perivillous fibrin deposition: A manifestation of maternal antifetal rejection? Am J Reprod Immunol 2013 Oct;70(4):285–98.Google Scholar
Henderson, JT, Whitlock, EP, O’Conner, E, Senger, CA, Thompson, JH, Rowland, MG. Low-Dose Aspirin for the Prevention of Morbidity and Mortality from Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US): 2014 Apr Report No:14-05207-EF-1 2014 Apr.CrossRefGoogle ScholarPubMed